AML Diagnostic
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
9
NCT03197714
Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Phase: Phase 1
Role: Collaborator
Start: Sep 7, 2017
Completion: Mar 31, 2020
Loading map...